Summary
Adamis Pharmaceuticals Corporation (Adamis), formerly Cellegy Pharmaceuticals, Inc., is a specialty biopharmaceutical company that develops and commercializes products in the therapeutic areas of allergy and respiratory diseases. Its lead pipeline product, Epinephrine Pre-filled Syringe (PFS) is developed for serious and common anaphylactic reactions such as foods, insect stings, medications and latex. The company’s pipeline also include specialty pharmaceuticals products such as APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease; APC-2000 for the treatment of bronchospasms; and APC-3000, an HFA inhaled nasal steroid product for the treatment of allergic rhinitis. Adamis provides its products for patients, physicians, and healthcare organizations. Adamis is headquartered in San Diego, California, the US.
Adamis Pharmaceuticals Corporation (ADMP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Adamis Pharmaceuticals Corporation, Medical Devices Deals, 2010 to YTD 2016 9
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Adamis Pharma Acquires Cancer Vaccine Technology From The Regents Of The University Of California 12
Partnerships 13
Adamis Enters Into Co-Development Agreement With Beximco 13
Merger 14
La Jolla Pharma Terminates Merger With Adamis Pharma 14
Licensing Agreements 16
Watson Labs Terminates Licensing Agreement with Adamis Pharma 16
Adamis Pharma Enters Into Licensing Agreement With Colby Pharma 18
Equity Offering 20
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 20
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 22
Adamis Pharma Raises USD11.5 Million in Public Offering of Shares 24
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 26
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For US$25.5 Million 28
Adamis Pharma Completes Final Tranche Of Private Placement Of Shares For US$0.5 Million 30
Debt Offering 31
Adamis Pharma Completes Private Placement Of Debentures For US$0.6 Million 31
Adamis Pharma Completes Private Placement Of Senior Convertible Note For US$0.5 Million 33
Adamis Pharma Completes Private Placement Of Senior Convertible Note Due 2013 For US$1 Million 34
Adamis Pharma Completes Private Placement Of Senior Secured Convertible Notes For US$1.5 Million 35
Adamis Pharmaceuticals Corporation - Key Competitors 36
Key Employees 37
Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
List Of Tables
List of Tables
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Adamis Pharmaceuticals Corporation, Deals By Therapy Area, 2010 to YTD 2016 8
Adamis Pharmaceuticals Corporation, Medical Devices Deals, 2010 to YTD 2016 9
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Adamis Pharma Acquires Cancer Vaccine Technology From The Regents Of The University Of California 12
Adamis Enters Into Co-Development Agreement With Beximco 13
La Jolla Pharma Terminates Merger With Adamis Pharma 14
Watson Labs Terminates Licensing Agreement with Adamis Pharma 16
Adamis Pharma Enters Into Licensing Agreement With Colby Pharma 18
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 20
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 22
Adamis Pharma Raises USD11.5 Million in Public Offering of Shares 24
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 26
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For US$25.5 Million 28
Adamis Pharma Completes Final Tranche Of Private Placement Of Shares For US$0.5 Million 30
Adamis Pharma Completes Private Placement Of Debentures For US$0.6 Million 31
Adamis Pharma Completes Private Placement Of Senior Convertible Note For US$0.5 Million 33
Adamis Pharma Completes Private Placement Of Senior Convertible Note Due 2013 For US$1 Million 34
Adamis Pharma Completes Private Placement Of Senior Secured Convertible Notes For US$1.5 Million 35
Adamis Pharmaceuticals Corporation, Key Competitors 36
Adamis Pharmaceuticals Corporation, Key Employees 37
Adamis Pharmaceuticals Corporation, Subsidiaries 38
Lisst Of Figures
List of Figures
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Adamis Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Adamis Pharmaceuticals Corporation, Medical Devices Deals, 2010 to YTD 2016 9
